Overview


According to FutureWise analysis the market for anastomosis device in 2023 is US$ 3.26 billion, and is expected to reach US$ 6.26 billion by 2031 at a CAGR of 8.50%.

An anastomosis device is a medical instrument or device used by surgeons to create a link between two tubular forms, such as blood vessels, intestines, or hollow organs within the body. The purpose of an anastomosis is to restore or establish proper blood flow, continuity, or flow of fluids between the two structures. Anastomosis devices are essential tools in various surgical procedures and are designed to facilitate a secure and often precise attachment between the two ends of the tubular structures. Anastomosis devices come in various forms, and their selection depends on the specific surgical procedure and the type of tissues or vessels being joined. Some common types of anastomosis devices include sutures, staples, clips, and specialized mechanical devices. These devices help surgeons create a strong and leak-resistant connection, ensuring that blood or fluids can flow through the joined structures properly.

Anastomosis devices are indispensable tools in the field of surgery, finding applications across a spectrum of medical specialties. These devices play a pivotal role in re-establishing connections between tubular structures within the body, ensuring the restoration of blood flow, continuity, and function. In vascular surgery, anastomosis devices are routinely used to join blood vessels, enabling life-saving procedures like coronary artery bypass grafting and aneurysm repair. Gastrointestinal surgeons rely on these devices to reconnect sections of the intestines during procedures, fostering digestive continuity. Cardiac, reconstructive, urologic, and plastic surgeons utilize anastomosis devices for various applications, such as transplant surgeries, tissue reconstructions, and microvascular procedures, facilitating the reattachment of severed limbs or digits. In neurosurgery and ear, and throat surgery, these devices ensure the reconnection of blood vessels within the brain, spinal cord, or airway structures. Overall, anastomosis devices are indispensable in modern medicine, enabling surgeons to perform complex procedures that restore vital connections within the body and improve patients' health and quality of life.

FutureWise Market Research has published a report that provides an insightful analysis of Anastomosis Device Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Anastomosis Device Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Johnson and Johnson
  • Medtronic plc.
  • B. Braun Melsungen A.G.
  • Smith and Nephew
  • EndoEvolution LLC.
  • CryoLife, Inc.
  • Becton, Dickinson and Company
  • CONMED Corporation
  • Intuitive Surgical, Inc.
  • Boston Scientific Corporation
  • Baxter International, Inc.
  • Péters Surgical
  • Biosintex
  • Meril Life Sciences

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development for Anastomosis Device Market:

In January 2023, Lydus Medical achieved FDA clearance for its innovative medical device, the Vesseal. The Vesseal is a cutting-edge microvascular anastomosis suture deployment system designed for standardized omni-vessel anastomoses. This device revolutionizes surgical procedures by providing a simple, rapid, secure, and highly effective method for creating vascular connections, ensuring safer and more efficient surgeries.

The market for anastomosis devices is experiencing robust growth, fueled by several key factors. Firstly, the increasing number of surgical procedures, including colectomy, coronary artery bypass grafting (CABG), organ transplants, and cardiovascular surgeries, is driving demand for anastomosis devices. For example, CABG surgeries, which are the most commonly performed critical surgical procedures in the United States, reached nearly 400,000 annually, according to StatPearls. Similarly, the high prevalence of organ transplants, with about 40,000 performed in the U.S. in 2021, including kidney and live transplants, contributes significantly to the demand for anastomosis devices. Furthermore, the growth in surgical procedures related to trauma, hip and knee replacements, and chronic diseases like cardiovascular diseases necessitating surgery is a primary driver for the anastomosis devices market. This trend is evident in the substantial number of heart surgeries, including heart valve procedures, coronary artery bypass grafting, and, as reported in research from the Journal of Thoracic and Cardiovascular Surgery. Additionally, key market players are taking strategic initiatives such as product launches, mergers, acquisitions, and partnerships, which are expected to further propel market growth. For example, Medicare Part B coverage for specific cardiac procedures and the launch of advanced surgical staplers by companies like Johnson & Johnson are enhancing the market's growth prospects. However, the high cost associated with some of these devices and treatments could also limit market growth. Additionally, the lack of advanced healthcare infrastructure in certain regions may impede the adoption of anastomosis devices.

By Type

  • Surgical Staplers
    • Manual
    • Powered
  • Surgical Sutures
    • Absorbable Sutures
      • Synthetic Sutures
        • Polyglactin 910 Sutures
        • Poliglecaprone 25 Sutures
        • Polydioxanone Sutures
        • Polyglycolic Acid Sutures
        • Other Synthetic Sutures
    • Natural Sutures
  • Non-absorbable Sutures
    • Polypropylene
    • Nylon
    • Stainless Steel
    • Other Non-absorbable Sutures
  • Automated Suturing Devices
    • Disposable
    • Reusable
  • Surgical Sealants and Adhesives
    • Natural/Biological
      • Fibrin-based
      • Collagen-based
      • Albumin-based
    • Synthetic and Semisynthetic
      • PEG Hydrogel-based
      • Cyanoacrylate-based
      • Urethane-based
      • Other Synthetic and Semisynthetic Sealants Adhesives

By Application

  • Gastrointestinal Surgeries
  • Cardiovascular and Thoracic Surgeries
  • Others Applications

By End User

  • Hospitals
  • Ambulatory Surgical Centers and Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. North America's significant share in the global anastomosis devices market is driven by a well-established regulatory framework, increasing awareness about surgical interventions, a high prevalence of chronic diseases, and a notable volume of medical procedures, particularly surgeries. These factors collectively contribute to the region's sustained growth in the anastomosis devices market. For example, the United States sees an annual volume of approximately 350,000 coronary artery bypass grafting (CABG) surgeries, as reported by the University of Alabama at Birmingham in April 2021. The prevalence of cardiovascular disorders and obesity rates in North America further fuels the growth of the market in this region. According to the CDC's October 2022 update, approximately 18.2 million adults in the United States suffer from coronary artery disease, with roughly 70% of these patients’ undergoing surgery. The United States also records nearly 35 million hospital stays annually, indicating a substantial demand for medical procedures and surgical devices like anastomosis devices.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anastomosis Device Market By Type, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anastomosis Device Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anastomosis Device Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anastomosis Device Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anastomosis Device Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Surgical Staplers
         1.1. Manual
         1.2. Powered
        2. Surgical Sutures
         2.1. Absorbable Sutures
          2.1.1. Synthetic Sutures
           2.1.1.1. Polyglactin 910 Sutures
           2.1.1.2. Poliglecaprone 25 Sutures
           2.1.1.3. Polydioxanone Sutures
           2.1.1.4. Polyglycolic Acid Sutures
           2.1.1.5. Other Synthetic Sutures
         2.2. Natural Sutures
        3. Non-absorbable Sutures
         3.1. Polypropylene
         3.2. Nylon
         3.3. Stainless Steel
         3.4. Other Non-absorbable Sutures
        4. Automated Suturing Devices
         4.1. Disposable
         4.2. Reusable
        5. Surgical Sealants and Adhesives
         5.1. Natural/Biological
          5.1.1. Fibrin-based
          5.1.2. Collagen-based
          5.1.3. Albumin-based
         5.2. Synthetic and Semisynthetic
          5.2.1. PEG Hydrogel-based
          5.2.2. Cyanoacrylate-based
          5.2.3. Urethane-based
          5.2.4. Other Synthetic and Semisynthetic Sealants Adhesives

  • 8.   Anastomosis Device Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Gastrointestinal Surgeries
        2. Cardiovascular and Thoracic Surgeries
        3. Other Applications

  • 9.   Anastomosis Device Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers & Clinics

  • 10.   North America Anastomosis Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anastomosis Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anastomosis Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anastomosis Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Johnson & Johnson
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic plc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. B. Braun Melsungen A.G.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Smith & Nephew
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. EndoEvolution LLC.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. CryoLife, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton, Dickinson and Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. CONMED Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Intuitive Surgical, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Boston Scientific Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Baxter International, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Péters Surgical
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Biosintex
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Meril Life Sciences
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Cardiovascular Proximal Anastomosis Devices Market

Read More

Cardiovascular Anastomosis Devices Market

Read More
Partner

Our Clients